Kazuhiro Muramatsu

Kazuhiro Muramatsu

Auto-generated profile, based on publicly available information

Kazuhiro Muramatsu

Department of Electrical and Electronic Engineering, Saga University, Saga, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2013 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
HSHirotomo Saitsu
Hirotomo Saitsu
TNTaki Nishimura
Taki Nishimura
KMKazuhiro Muramatsu
Kazuhiro Muramatsu
HKHirofumi Kodera
Hirofumi Kodera
SKSatoko Kumada
Satoko Kumada
NMNaomichi Matsumoto
Naomichi Matsumoto

16 January 2017 in Nature Genetics
Verified
Journal Article
Open access
PDF file
RLRea M Lardelli
Rea M Lardelli
ASAshleigh E Schaffer
Ashleigh E Schaffer
VEVeerle R C Eggens
Veerle R C Eggens
MZMaha S Zaki
Maha S Zaki
SGStephanie Grainger
Stephanie Grainger
JGJoseph G Gleeson
Joseph G Gleeson
Jens Lykke-Andersen, Frank Baas, Joseph Gleeson and colleagues report that mutations in the 3′ exonuclease TOE1 cause pontocerebellar hypoplasia type 7. They further show that these mutations result in the accumulation of incompletely processed small nuclear RNAs, leading to severe, early-onset neurodegeneration. Deadenylases are best known for degrading the poly(A) tail during mRNA decay. The deadenylase family has expanded throughout evolution and, in mammals, consists of 12 Mg2+-dependent 3′-end RNases with substrate specificity that is mostly unknown1. Pontocerebellar hypoplasia type 7 (PCH7) is a unique recessive syndrome characterized by neurodegeneration and ambiguous genitalia2. We studied 12 human families with PCH7, uncovering biallelic, loss-of-function mutations in TOE1, which encodes an unconventional deadenylase3,4. toe1-morphant zebrafish displayed midbrain and hindbrain degeneration, modeling PCH-like structural defects in vivo. Surprisingly, we found that TOE1 associated with small nuclear RNAs (snRNAs) incompletely processed spliceosomal. These pre-snRNAs contained 3′ genome-encoded tails often followed by post-transcriptionally added adenosines. Human cells with reduced levels of TOE1 accumulated 3′-end-extended pre-snRNAs, and the immunoisolated TOE1 complex was sufficient for 3′-end maturation of snRNAs. Our findings identify the cause of a neurodegenerative syndrome linked to snRNA maturation and uncover a key factor involved in the processing of snRNA 3′ ends.

19 July 2016 in Clinical Genetics
Verified
Journal Article
Closed access
PDF file
TST. Suzuki
T. Suzuki
NMN. Miyake
N. Miyake
YTY. Tsurusaki
Y. Tsurusaki
NON. Okamoto
N. Okamoto
AAA. Alkindy
A. Alkindy
NMN. Matsumoto
N. Matsumoto

23 May 2002 in Cancer
Verified
Journal Article
Open access
PDF file
Shinsaku ImashukuShinsaku Imashuku
Shinsaku Imashuku
NHNobuyuki Hyakuna
Nobuyuki Hyakuna
TFTetsunori Funabiki
Tetsunori Funabiki
KIKoichiro Ikuta
Koichiro Ikuta
MSMasahiro Sako
Masahiro Sako
EIEiichi Ishii
Eiichi Ishii
BACKGROUND: Familial hemophagocytic lymphohistiocytosis HLH (FHL) is fatal, unless patients are rescued with hematopoietic stem cell transplantation (SCT). Although the molecular identification of FHL now is possible at least in part from perforin gene study, many cases escape detection or never are tested due to the lack of specific hallmarks, making diagnosis difficult. To the authors' knowledge, it remains to be determined whether persistently low natural killer cell (NK) activity and a high incidence of central nervous system (CNS) disease increase the probability of FHL.METHODS: The authors analyzed 42 HLH patients age < 2 years, 13 of whom developed overt CNS disease and 5 of whom demonstrated persistently deficient NK activity (Group 1). The remaining 24 patients had no CNS disease and had NK activity of moderate decrease to within the normal range (Group 2).RESULTS: In Group 1, CNS symptoms were detected in 6 cases within 1 month and between 4.5–9 months in 6 other patients. In these cases, spotty lesions demonstrating a high T2 signal in the white matter were noted on brain magnetic resonance imaging. The survival was significantly poor for patients in Group 1 unless they were rescued with SCT, which was performed in 5 of the 13 patients with CNS disease and in all 5 patients with persistent NK activity deficiency. SCT was successful in 9 patients, with no CNS sequelae reported after the transplantation. Conversely, the prognosis of the 24 patients in Group 2 was better and only 1 patient required SCT.CONCLUSIONS: Very young HLH patients (age < 2 years) who are at high risk of fatal FHL with persistently deficient NK activity and/or overt CNS disease require appropriate SCT to reverse CNS disease and achieve a complete cure. Cancer 2002;94:3023–31. © 2002 American Cancer Society.DOI 10.1002/cncr.10515

17 February 2017 in IEEE Transactions on Magnetics
Verified
Journal Article
Closed access
JYJiaxin Yuan
Jiaxin Yuan
YZYongheng Zhong
Yongheng Zhong
YLYang Lei
Yang Lei
CTCuihua Tian
Cuihua Tian
WGWeimin Guan
Weimin Guan
BCBaichao Chen
Baichao Chen
The saturated core fault current limiter (SFCL) is one of the most effective methods for limiting fault current. A permanent magnet (PM)-biased SFCL (PFCL) can reduce DC bias current and additional energy consumption. However, the thermal stability of NdFeB PMs in PFCL poses a major challenge. This paper proposes a novel hybrid-type SFCL (HSFCL) topology that can reduce this risk. In the HSFCL, a hybrid PM/DC coil is designed to saturate the core, and a fault-limiting reactor is used to guarantee fault-clipping performance. The new structure provides air-gap branches for the time-varying magnetic field produced by alternating current, which reduces the eddy current in the PMs and enhances their stability. Electromagnetic coupling is used to analyze the operating principles and characteristics of HSFCL. Finite-element analysis simulations were performed using Maxwell and compared with verification experiments, proving that HSFCL is efficient in fault clipping and PM reliability enhancement.

1 June 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
KMKazuhiro Muramatsu
Kazuhiro Muramatsu
YHYukiko Hashimoto
Yukiko Hashimoto
TUTakefumi Uemura
Takefumi Uemura
MKMasataka Kunii
Masataka Kunii
RHReiko Harada
Reiko Harada
AHAkihiro Harada
Akihiro Harada